文献速递消化内镜消化道肿瘤与早癌

内镜黏膜下剥离术治疗早期巴雷特食管肿瘤:一项Meta分析

Endoscopic submucosal dissection for early Barrett's neoplasia: a meta-analysis.
PubMed 文献 · Gastrointest Endosc · 2017-10-06

该Meta分析纳入11项研究(501例患者,524处病变),评估内镜黏膜下剥离术治疗早期巴雷特食管肿瘤的安全性和有效性。汇总整块切除率为92.9%,R0切除率为74.5%,治愈性切除率为64.9%,穿孔率为1.5%,出血率为1.7%,食管狭窄率为11.6%,治愈性切除后复发率为0.17%(平均随访22.9个月)。结论认为内镜黏膜下剥离术与高整块切除率、可接受的安全性及低复发相关,应考虑作为巴雷特食管肿瘤治疗手段的一部分。

要点

  • 内镜黏膜下剥离术治疗早期巴雷特食管肿瘤的汇总整块切除率为92.9%。
  • 汇总R0切除率为74.5%,治愈性切除率为64.9%。
  • 穿孔率1.5%,出血率1.7%,食管狭窄率11.6%,治愈性切除后复发率0.17%。

核心结论

  • 内镜黏膜下剥离术治疗早期巴雷特食管肿瘤与高整块切除率、可接受的安全性及治愈性切除后低复发相关。
  • 内镜黏膜下剥离术应考虑作为巴雷特食管肿瘤治疗手段的一部分。

研究设计与样本

  • 检索了三个在线数据库。
  • 使用Cochran Q检验和I2检验异质性,根据研究间异质性采用固定效应或随机效应模型进行合并。
  • 纳入11项研究,共501例患者、524处病变。
  • 对主要结局,通过线性回归分析评估潜在异质性来源。

主要发现

  • 平均病变大小为27 mm(95%CI,20.9-33.1)。
  • 汇总整块切除率为92.9%(95%CI,90.3%-95.2%)。
  • 汇总R0(完全)切除率为74.5%(95%CI,66.3%-81.9%),治愈性切除率为64.9%(95%CI,55.7%-73.6%)。
  • R0或治愈性切除率与研究地区(亚洲 vs 西方)、巴雷特食管长度、病变特征、手术时间或随访时长无关联。
  • 穿孔和出血的汇总估计分别为1.5%(95%CI,0.4%-3.0%)和1.7%(95%CI,0.6%-3.4%),食管狭窄率为11.6%(95%CI,0.9%-29.6%)。

临床怎么用

  • 作者认为内镜黏膜下剥离术应考虑作为巴雷特食管肿瘤治疗手段的一部分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The role of endoscopic submucosal dissection (ESD) in Barrett's esophagus (BE) is not well established. This meta-analysis aimed to evaluate the safety and efficacy of ESD for the management of early BE neoplasia. METHODS: Three online databases were searched. The Cochran Q test and I2 were used to test for heterogeneity. Pooling was conducted using either fixed- or random-effects models depending on heterogeneity across studies. For the main outcomes, potential sources of heterogeneity were evaluated via linear regression analysis. RESULTS: Eleven studies (501 patients, 524 lesions) were included. Mean lesion size was 27 mm (95% confidence interval [CI], 20.9-33.1). Pooled estimate for en bloc resection was 92.9% (95% CI, 90.3%-95.2%). The pooled R0 (complete) and curative resection rates were 74.5% (95% CI, 66.3%-81.9%) and 64.9% (95% CI, 55.7%-73.6%), respectively. There was no association between R0 or curative resection rates and study setting (Asia vs West), length of BE, lesion characteristics, procedural time, or length of follow-up. The pooled estimates for perforation and bleeding were 1.5% (95% CI, .4%-3.0%) and 1.7% (95% CI, .6%-3.4%), respectively. Esophageal stricture rate was 11.6% (95% CI, .9%-29.6%). Incidence of recurrence after curative resection was .17% (95% CI, 0%-.3%) at a mean follow-up 22.9 months (95% CI, 17.5-28.3). CONCLUSIONS: ESD for early BE neoplasia is associated with a high en bloc resection rate, acceptable safety profile, and low recurrence after curative resection. ESD should be considered as part of the armamentarium for the management of BE neoplasia.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Yang D, Zou F, Xiong S, et al. Endoscopic submucosal dissection for early Barrett's neoplasia: a meta-analysis. Gastrointest Endosc. 2017. PMID: 28993137. doi:10.1016/j.gie.2017.09.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。